Wei Wei, Li Siwei, Hao Erwei, Pan Xianglong, Xie Jinling, Du Zhengcai, Hou Xiaotao, Deng Jiagang
Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning, Guangxi 530200, China.
Faculty of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Curr Drug Metab. 2022;23(8):652-665. doi: 10.2174/1389200223666220817112937.
In this study, we aim to establish an integrated research strategy for the rapid chemical profiling of Compound Huanggen Granules (CHG) and absorbed prototypes in plasma by integrating the UHPLC-Q-TOF-MS method and data post-processing strategy, to provide some valuable research basis for the further studies on the quality control, pharmacokinetics and pharmacodynamics of CHG.
Compound Huanggen Granules (CHG), a traditional Chinese medicine (TCM) hospital preparation, has long been used in clinical practice for the prevention and treatment of liver fibrosis. However, due to the lack of in vitro chemical and in vivo metabolism studies, its pharmacodynamic material basis is still unrevealed.
To simplify the mass data post-processing process and enhance the structural identification efficiency by reducing the possibility of false positive, and rapidly identify the absorbed prototypes in plasma after oral administration of CHG.
An analytical strategy integrating ultra high-performance liquid chromatography coupled with quadrupletime- of-flight mass spectrometry (UHPLC-Q-TOF-MS, E represents collision energy) method and data postprocessing strategy based on a self-built in-house components database was established and utilized for the rapid characterization of the multi-constituents of CHG and prototypes in cynomolgus monkey plasma after oral administration.
As a result, a total of 81 compounds, including 14 phenolic acids, 6 coumarins, 25 flavonoids, 5 anthraquinones, 5 phenylpropanoids, 15 triterpenoid saponins, and 11 others, were plausibly or unambiguously identified based on their accurate masses, and MS/MS fragment pathways analysis, and also by comparison of retention time and MS data with reference standards. In the in vivo study, according to the extracted ion chromatograms (EICs) of identified components, 34 absorbed prototypical components were rapidly identified in cynomolgus monkey plasma after oral administration.
It was demonstrated that the data post-processing strategy applied in this study could greatly simplify the data post-processing process and enhance the structural identification efficiency by reducing the possibility of false positives, and the results obtained might be helpful for further studies on the quality control, pharmacokinetics and pharmacodynamics of CHG.
在本研究中,我们旨在通过整合超高效液相色谱-四极杆飞行时间质谱(UHPLC-Q-TOF-MS)方法和数据后处理策略,建立一种用于复方黄根颗粒(CHG)快速化学表征及血浆中吸收原型的综合研究策略,为CHG的质量控制、药代动力学和药效学的进一步研究提供一些有价值的研究依据。
复方黄根颗粒(CHG)是一种中药医院制剂,长期以来一直用于临床预防和治疗肝纤维化。然而,由于缺乏体外化学和体内代谢研究,其药效物质基础仍未明确。
简化大量数据的后处理过程,通过减少假阳性的可能性提高结构鉴定效率,并快速鉴定口服CHG后血浆中的吸收原型。
建立了一种将超高效液相色谱与四极杆飞行时间质谱联用(UHPLC-Q-TOF-MS,E代表碰撞能量)的分析策略以及基于自建内部成分数据库的数据后处理策略,并将其用于口服给药后食蟹猴血浆中CHG多种成分及原型的快速表征。
结果显示,基于准确质量数、MS/MS碎片途径分析,并通过保留时间和MS数据与参考标准品的比较,共合理或明确鉴定出81种化合物,包括14种酚酸、6种香豆素、25种黄酮类、5种蒽醌、5种苯丙素、15种三萜皂苷以及11种其他化合物。在体内研究中,根据已鉴定成分的提取离子色谱图(EIC),口服给药后在食蟹猴血浆中快速鉴定出34种吸收的原型成分。
结果表明,本研究中应用的数据后处理策略可极大简化数据后处理过程,并通过减少假阳性的可能性提高结构鉴定效率,所得结果可能有助于CHG质量控制、药代动力学和药效学的进一步研究。